Pharmacovigilance and Drug Safety Software Market Report 2031
The pharmacovigilance and drug safety software market was valued at US$ 1.97 billion in 2021 and is expected to reach US$ 3.29 billion by 2031. The market is expected to register a CAGR of 5.9% in 2023–2031. Artificial intelligence in pharmacovigilance will likely remain a key pharmacovigilance and drug safety software market trend.
Pharmacovigilance and Drug Safety Software Market Analysis
Pharmacovigilance (PV) plays an essential role in the healthcare system through assessment, monitoring, and finding drug interactions and their effects in humans. Pharmacovigilance helps companies monitor adverse drug reaction events during the trial and post-marketing periods. Key factors driving the market are rising adverse drug reaction incidences and the globalization of pharmacovigilance, which have been boosting the market over the years. However, expensive technology is likely to have a negative impact on market growth in the coming years.
Pharmacovigilance and Drug Safety Software Market Overview
The rise in a high volume of pharmacovigilance data and ADR events during recent years across the globe is a prime contributing factor to the rising demand for sophisticated pharmacovigilance and drug safety software. The industry players operating in the market of pharmacovigilance (PV) and drug safety market include AB Cube, United BioSource LLC, ARISGLOBAL LLC, Sparta Systems, Inc., Oracle Corporation, Sarjen Systems Pvt. Ltd., EXTEDO, ENNOV, Max Application, and Anju Software, Inc. The players operating in the pharmacovigilance (PV) and drug safety software market have been focusing on various organic and inorganic growth strategies during the previous years.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmacovigilance and Drug Safety Software Market: Strategic Insights
Market Size Value in US$ 160.67 Million in 2019 Market Size Value by US$ 292.97 Million by 2027 Growth rate CAGR of 7.6% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Naveen
Have a question?
Naveen will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmacovigilance and Drug Safety Software Market: Strategic Insights
| Market Size Value in | US$ 160.67 Million in 2019 |
| Market Size Value by | US$ 292.97 Million by 2027 |
| Growth rate | CAGR of 7.6% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Naveen
Have a question?
Naveen will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pharmacovigilance and Drug Safety Software Market Drivers and Opportunities
Globalization Of Pharmacovigilance
Pharmacovigilance, which refers to the procedures for tracking and assessing adverse drug responses, is an essential part of clinical practice, public health initiatives, and efficient drug control systems. The volume of data processed increased due to the reported number of Adverse Drug Reactions (ADRs) within the existing Uppsala Monitoring Center-coordinated global network of pharmacovigilance facilities. Pharmacovigilance is becoming increasingly common in many nations, and it is an essential and crucial component of clinical research. However, at the turn of the millennium, pharmacovigilance faces significant challenges in the aspect of better safety and monitoring of drugs.
Growth Opportunities in Developing Countries– An Opportunity in Pharmacovigilance and Drug Safety Software Market
The emerging Asian Pacific markets are creating significant opportunities for key market players to expand their businesses. It will likely be a prime factor contributing to market growth in the coming years. Most players concentrate on developing markets such as India and China, owing to the presence of many clinical research organization and business process outsourcing firms in countries.
Various players from the pharmaceutical industry have been investing a significant amount of their revenue in research and development activities to develop better medicines to be used in the healthcare industry. Asia Pacific is foreseen to register the fastest growth during the forecast period. The presence of key pharmaceutical companies in the region contributes to APAC's market growth. These activities in the region are increasing the demand for pharmacovigilance and drug safety software’s.
Pharmacovigilance and Drug Safety Software Market Report Segmentation Analysis
Key segments that contributed to the derivation of the pharmacovigilance and drug safety software market analysis are disorder and service provider.
- Based on software type, the pharmacovigilance and drug safety software market is segmented into adverse event reporting software, drug safety audits software, issue tracking software, fully integrated software. The adverse event reporting software segment held a larger market share in 2023.
- By delivery mode, the pharmacovigilance and drug safety software market is segmented into on-premise, cloud-based. The on-premise segment held the largest share of the market in 2023.
- By End Users, the pharmacovigilance and drug safety software market is classified into pharmaceutical and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, pharmacovigilance service providers. The contract research organizations (CROs) segment held the largest share of the market in 2023.
Pharmacovigilance and Drug Safety Software Market Share Analysis by Geography
The geographic scope of the pharmacovigilance and drug safety software market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
The United States offers significant growth opportunities in the Pharmacovigilance (PV) and drug safety software market, which is expected to drive the market’s growth considerably. The Institute of Medicine reported in 2000 that from 44,000 to 98,000 deaths occur annually from medical errors, and an estimated 7,000 deaths occur due to Adverse Drug Reactions (ADRs).
According to the U.S Food and Drugs Admiration, a study conducted in the hospital on hospitalized patient populations has placed much higher estimates on the overall incidence of serious Adverse Drug Reactions (ADRs). These studies estimate that 6.7% of hospitalized patients have a serious adverse drug reaction with a fatality rate of 0.32%. According to this study data, it estimates that there are more than 2,216,000 serious ADRs in hospitalized patients, causing over 106,000 deaths annually, which indicates that ADRs are the 4th leading cause of death ahead of pulmonary disease, diabetes, AIDS, pneumonia, accidents, and automobile deaths.
Pharmacovigilance and Drug Safety Software Market Report Scope
Pharmacovigilance and Drug Safety Software Market News and Recent Developments
The pharmacovigilance and drug safety software market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for speech and language disorders and strategies:
- To move their pharmacovigilance from Contract Research Organization (CRO) services to in-house practices using this cutting-edge pharmacovigilance software, PegBio chose ArisGlobal's flagship product, LifeSphere MultiVigilance. (PegBio: Pearl, Press Release, 2022).
Dotmatics, the leader in scientific software for research and development that links data, science, and decision-making, has released a new platform for scientific research and development called Small Molecule Drug Discovery Solution. It features enhanced data management features and pre-configured workflows. The solution makes innovation easier for businesses by using best practices developed over the company's more than 15 years of supporting small molecule drug research. (Source: Dotmatics, Press Release, 2022)
Pharmacovigilance and Drug Safety Software Market Report Coverage and Deliverables
The “Pharmacovigilance and Drug Safety Software Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Software Type ; Delivery Mode ; and End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Integration of cloud-based platforms that offers real-time access to data from anywhere across the globe, enabling pharmaceutical companies to respond swiftly to emerging safety concerns.
ArisEurope, ICON plc, Syneos Health, Accenture, IQVIA, Genpact, Cognizant, Paraxel International Corporation, Laboratory Corporation of America Holdings, Max Application, Clinevo Technologies, Qinecsa Solutions, AB Cube, and Veeva Systems are among the key players operating in the global pharmacovigilance and drug safety software market.
The pharmacovigilance and drug safety software market was valued at US$ 214.39 billion in 2023 and is anticipated to grow at a CAGR of 6.7% over the forecast period.
The rising cases of adverse drug reactions (ADRs) worldwide owing to the increasing prevalence of chronic diseases drives the market growth.
Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.
The software segment led the pharmacovigilance and drug safety software market with a significant share in 2023.
The pharmacovigilance and drug safety software market are expected to reach US$ 359.30 million by 2031 and is expected to register a CAGR of 6.7% during 2023–2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Pharmacovigilance and Drug Safety Software Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 Software/Service Providers:
4.3.2 System Integrators:
4.3.3 Regulatory Bodies:
4.3.4 End-Users:
4.3.5 List of Vendors in the Value Chain
5. Pharmacovigilance and Drug Safety Software Market – Key Market Dynamics
5.1 Pharmacovigilance and Drug Safety Software Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rise in Incidences of Adverse Drug Reactions
5.2.2 Globalization of Pharmacovigilance
5.2.3 Surge in Drug Development Spending
5.3 Market Restraints
5.3.1 High Installation and Maintenance Costs
5.4 Market Opportunities
5.4.1 Integration of Software with AI, ML, and NLP
5.5 Future Trends
5.5.1 Cloud-Based Pharmacovigilance and Drug Safety Software:
5.6 Impact of Drivers and Restraints:
6. Pharmacovigilance and Drug Safety Software Market – Global Market Analysis
6.1 Pharmacovigilance and Drug Safety Software Market Revenue (US$ Million), 2021–2031
6.2 Pharmacovigilance and Drug Safety Software Market Forecast Analysis
7. Pharmacovigilance and Drug Safety Software Market Analysis – by Offering
7.1 Software
7.1.1 Overview
7.1.2 Software: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Services
7.2.1 Overview
7.2.2 Services: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
8. Pharmacovigilance and Drug Safety Software Market Analysis – by Deployment
8.1 Cloud
8.1.1 Overview
8.1.2 Cloud: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
8.2 On Premises
8.2.1 Overview
8.2.2 On Premises: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
9. Pharmacovigilance and Drug Safety Software Market Analysis – by Enterprise Size
9.1 Large Enterprises
9.1.1 Overview
9.1.2 Large Enterprises: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
9.2 SMEs
9.2.1 Overview
9.2.2 SMEs: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
10. Pharmacovigilance and Drug Safety Software Market Analysis – by Form
10.1 Standard
10.1.1 Overview
10.1.2 Standard: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Customized
10.2.1 Overview
10.2.2 Customized: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
11. Pharmacovigilance and Drug Safety Software Market Analysis – by Functionality
11.1 Signal and Risk Management
11.1.1 Overview
11.1.2 Signal and Risk Management: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
11.2 Issue Tracking and Adverse Event Tracking
11.2.1 Overview
11.2.2 Issue Tracking and Adverse Event Tracking: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Case Management
11.3.1 Overview
11.3.2 Case Management: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Clinical Safety Management and Clinical Trial Safety
11.4.1 Overview
11.4.2 Clinical Safety Management and Clinical Trial Safety: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
11.5 Quality and Compliance
11.5.1 Overview
11.5.2 Quality and Compliance: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
11.6 Medical Writing
11.6.1 Overview
11.6.2 Medical Writing: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
11.7 Audit Support and Training Compliance
11.7.1 Overview
11.7.2 Audit Support and Training Compliance: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
11.8 Healthcare Analytics
11.8.1 Overview
11.8.2 Healthcare Analytics: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
11.9 Others
11.9.1 Overview
11.9.2 Others: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
12. Pharmacovigilance and Drug Safety Software Market Analysis – by End User
12.1 Pharmaceutical and Biotechnology Companies
12.1.1 Overview
12.1.2 Pharmaceutical and Biotechnology Companies: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
12.2 Contract Research Organizations
12.2.1 Overview
12.2.2 Contract Research Organizations: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
12.3 Business Process Outsourcing (BPO) Firms
12.3.1 Overview
12.3.2 Business Process Outsourcing (BPO) Firms: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
12.4 Others
12.4.1 Overview
12.4.2 Others: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13. Pharmacovigilance and Drug Safety Software Market – Geographical Analysis
13.1 Overview
13.2 North America
13.2.1 North America Pharmacovigilance and Drug Safety Software Market Overview
13.2.2 North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.2.3 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.2.3.1 North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Offering
13.2.4 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.2.4.1 North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Deployment
13.2.5 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.2.5.1 North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Enterprise Size
13.2.6 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.2.6.1 North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Form
13.2.7 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.2.7.1 North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Functionality
13.2.8 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.2.8.1 North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by End User
13.2.9 North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.2.9.1 North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.2.9.2 United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.2.9.2.1 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.2.9.2.2 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.2.9.2.3 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.2.9.2.4 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.2.9.2.5 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.2.9.2.6 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.2.9.3 Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.2.9.3.1 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.2.9.3.2 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.2.9.3.3 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.2.9.3.4 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.2.9.3.5 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.2.9.3.6 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.2.9.4 Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.2.9.4.1 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.2.9.4.2 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.2.9.4.3 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.2.9.4.4 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.2.9.4.5 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.2.9.4.6 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.3 Europe
13.3.1 Europe Pharmacovigilance and Drug Safety Software Market Overview
13.3.2 Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.3.3.1 Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Offering
13.3.4 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.3.4.1 Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Deployment
13.3.5 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.3.5.1 Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Enterprise Size
13.3.6 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.3.6.1 Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Form
13.3.7 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.3.7.1 Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Functionality
13.3.8 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.3.8.1 Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by End User
13.3.9 Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.3.9.1 Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.3.9.2 Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.3.9.2.1 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.3.9.2.2 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.3.9.2.3 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.3.9.2.4 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.3.9.2.5 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.3.9.2.6 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.3.9.3 France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.3.9.3.1 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.3.9.3.2 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.3.9.3.3 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.3.9.3.4 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.3.9.3.5 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.3.9.3.6 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.3.9.4 United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.3.9.4.1 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.3.9.4.2 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.3.9.4.3 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.3.9.4.4 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.3.9.4.5 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.3.9.4.6 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.3.9.5 Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.3.9.5.1 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.3.9.5.2 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.3.9.5.3 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.3.9.5.4 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.3.9.5.5 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.3.9.5.6 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.3.9.6 Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.3.9.6.1 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.3.9.6.2 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.3.9.6.3 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.3.9.6.4 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.3.9.6.5 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.3.9.6.6 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.3.9.7 Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.3.9.7.1 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.3.9.7.2 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.3.9.7.3 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.3.9.7.4 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.3.9.7.5 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.3.9.7.6 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.4 Asia Pacific
13.4.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market Overview
13.4.2 Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.4.3 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.4.3.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Offering
13.4.4 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.4.4.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Deployment
13.4.5 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.4.5.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Enterprise Size
13.4.6 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.4.6.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Form
13.4.7 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.4.7.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Functionality
13.4.8 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.4.8.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by End User
13.4.9 Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.4.9.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.4.9.2 China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.4.9.2.1 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.4.9.2.2 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.4.9.2.3 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.4.9.2.4 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.4.9.2.5 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.4.9.2.6 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.4.9.3 Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.4.9.3.1 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.4.9.3.2 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.4.9.3.3 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.4.9.3.4 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.4.9.3.5 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.4.9.3.6 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.4.9.4 India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.4.9.4.1 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.4.9.4.2 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.4.9.4.3 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.4.9.4.4 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.4.9.4.5 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.4.9.4.6 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.4.9.5 South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.4.9.5.1 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.4.9.5.2 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.4.9.5.3 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.4.9.5.4 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.4.9.5.5 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.4.9.5.6 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.4.9.6 Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.4.9.6.1 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.4.9.6.2 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.4.9.6.3 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.4.9.6.4 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.4.9.6.5 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.4.9.6.6 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.4.9.7 Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.4.9.7.1 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.4.9.7.2 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.4.9.7.3 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.4.9.7.4 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.4.9.7.5 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.4.9.7.6 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.5 Middle East and Africa
13.5.1 Middle East and Africa Pharmacovigilance and Drug Safety Software Market Overview
13.5.2 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.5.3 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.5.3.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Offering
13.5.4 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.5.4.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Deployment
13.5.5 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.5.5.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Enterprise Size
13.5.6 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.5.6.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Form
13.5.7 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.5.7.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Functionality
13.5.8 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.5.8.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by End User
13.5.9 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.5.9.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.5.9.2 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.5.9.2.1 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.5.9.2.2 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.5.9.2.3 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.5.9.2.4 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.5.9.2.5 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.5.9.2.6 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.5.9.3 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.5.9.3.1 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.5.9.3.2 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.5.9.3.3 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.5.9.3.4 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.5.9.3.5 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.5.9.3.6 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.5.9.4 South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.5.9.4.1 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.5.9.4.2 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.5.9.4.3 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.5.9.4.4 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.5.9.4.5 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.5.9.4.6 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.5.9.5 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.5.9.5.1 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.5.9.5.2 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.5.9.5.3 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.5.9.5.4 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.5.9.5.5 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.5.9.5.6 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.6 South and Central America
13.6.1 South and Central America Pharmacovigilance and Drug Safety Software Market Overview
13.6.2 South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.6.3 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.6.3.1 South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Offering
13.6.4 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.6.4.1 South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Deployment
13.6.5 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.6.5.1 South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Enterprise Size
13.6.6 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.6.6.1 South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Form
13.6.7 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.6.7.1 South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Functionality
13.6.8 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.6.8.1 South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by End User
13.6.9 South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.6.9.1 South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.6.9.2 Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.6.9.2.1 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.6.9.2.2 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.6.9.2.3 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.6.9.2.4 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.6.9.2.5 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.6.9.2.6 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.6.9.3 Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.6.9.3.1 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.6.9.3.2 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.6.9.3.3 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.6.9.3.4 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.6.9.3.5 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.6.9.3.6 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
13.6.9.4 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
13.6.9.4.1 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
13.6.9.4.2 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
13.6.9.4.3 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
13.6.9.4.4 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
13.6.9.4.5 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
13.6.9.4.6 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
14. Competitive Landscape
14.1 Heat Map Analysis by Key Players
14.2 Company Positioning & Concentration
15. Industry Landscape
15.1 Overview
15.2 Market Initiative
15.3 Merger and Acquisition
16. Company Profiles
16.1 ArisGlobal LLC
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Max Application
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Oracle Corp
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Veeva Systems Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 IQVIA Holdings Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 ICON Plc
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Cognizant Technology Solutions Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Accenture Plc
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Syneos Health Inc
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Genpact Ltd.
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
16.11 AB Cube S.A.S.
16.11.1 Key Facts
16.11.2 Business Description
16.11.3 Products and Services
16.11.4 Financial Overview
16.11.5 SWOT Analysis
16.11.6 Key Developments
16.12 Laboratory Corp of America Holdings
16.12.1 Key Facts
16.12.2 Business Description
16.12.3 Products and Services
16.12.4 Financial Overview
16.12.5 SWOT Analysis
16.12.6 Key Developments
16.13 Parexel International Corp
16.13.1 Key Facts
16.13.2 Business Description
16.13.3 Products and Services
16.13.4 Financial Overview
16.13.5 SWOT Analysis
16.13.6 Key Developments
16.14 Qinecsa Solutions
16.14.1 Key Facts
16.14.2 Business Description
16.14.3 Products and Services
16.14.4 Financial Overview
16.14.5 SWOT Analysis
16.14.6 Key Developments
16.15 Clinevo Technologies
16.15.1 Key Facts
16.15.2 Business Description
16.15.3 Products and Services
16.15.4 Financial Overview
16.15.5 SWOT Analysis
16.15.6 Key Developments
17. Appendix
17.1 Word Index
17.2 About the Insight Partners
List of Tables
Table 1. Pharmacovigilance and Drug Safety Software Market Segmentation
Table 2. List of Vendors
Table 3. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Table 4. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Offering
Table 5. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Deployment
Table 6. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Enterprise Size
Table 7. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Form
Table 8. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Functionality
Table 9. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 10. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 11. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 12. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 13. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 14. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 15. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 16. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 17. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 18. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 19. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 20. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 21. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 22. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 23. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 24. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 25. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 26. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 27. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 28. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 29. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 30. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 31. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 32. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 33. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 34. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 35. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 36. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 37. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 38. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 39. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 40. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 41. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 42. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 43. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 44. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 45. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 46. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 47. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 48. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 49. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 50. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 51. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 52. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 53. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 54. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 55. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 56. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 57. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 58. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 59. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 60. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 61. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 62. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 63. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 64. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 65. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 66. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 67. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 68. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 69. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 70. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 71. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 72. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 73. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 74. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 75. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 76. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 77. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 78. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 79. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 80. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 81. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 82. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 83. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 84. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 85. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 86. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 87. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 88. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 89. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 90. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 91. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 92. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 93. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 94. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 95. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 96. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 97. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 98. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 99. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 100. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 101. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 102. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 103. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 104. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 105. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 106. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 107. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 108. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 109. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 110. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 111. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 112. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 113. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 114. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 115. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 116. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 117. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 118. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 119. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 120. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 121. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 122. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 123. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 124. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 125. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 126. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 127. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 128. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 129. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 130. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 131. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 132. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 133. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 134. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 135. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 136. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 137. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 138. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 139. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 140. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 141. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 142. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 143. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 144. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 145. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 146. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 147. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 148. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 149. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 150. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 151. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 152. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 153. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 154. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 155. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 156. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 157. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 158. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 159. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 160. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 161. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 162. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 163. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 164. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 165. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 166. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 167. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 168. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 169. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 170. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 171. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 172. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 173. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 174. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 175. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 176. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 177. Company Positioning & Concentration
Table 178. List of Abbreviation
List of Figures
Figure 1. Pharmacovigilance and Drug Safety Software Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Million), 2021–2031
Figure 5. Pharmacovigilance and Drug Safety Software Market Share (%) – by Offering (2023 and 2031)
Figure 6. Software: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Services: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Pharmacovigilance and Drug Safety Software Market Share (%) – by Deployment (2023 and 2031)
Figure 9. Cloud: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. On Premises: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Pharmacovigilance and Drug Safety Software Market Share (%) – by Enterprise Size (2023 and 2031)
Figure 12. Large Enterprises: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. SMEs: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Pharmacovigilance and Drug Safety Software Market Share (%) – by Form (2023 and 2031)
Figure 15. Standard: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Customized: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Pharmacovigilance and Drug Safety Software Market Share (%) – by Functionality (2023 and 2031)
Figure 18. Signal and Risk Management: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Issue Tracking and Adverse Event Tracking: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Case Management: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Clinical Safety Management and Clinical Trial Safety: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Quality and Compliance: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Medical Writing: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Audit Support and Training Compliance: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Healthcare Analytics: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Others: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Pharmacovigilance and Drug Safety Software Market Share (%) – by End User (2023 and 2031)
Figure 28. Pharmaceutical and Biotechnology Companies: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 29. Contract Research Organizations: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. Business Process Outsourcing (BPO) Firms: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Others: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 32. Pharmacovigilance and Drug Safety Software Market Breakdown by Region, 2023 and 2031 (%)
Figure 33. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 35. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 36. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 37. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 38. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 39. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 40. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 41. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 46. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 47. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 48. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 49. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 50. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 51. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 60. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 61. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 62. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 63. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 64. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 65. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 66. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 67. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 68. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 69. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 72. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 73. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 74. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 75. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 76. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 77. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 78. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 79. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 80. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 81. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 82. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 83. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 84. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 85. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 86. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 87. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 88. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 89. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 90. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 91. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 92. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 93. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 94. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 95. Heat Map Analysis by Key Players
The List of Companies - Pharmacovigilance and Drug Safety Software Market
- ArisGlobal LLC
- Max Application
- Oracle Corp
- Veeva Systems Inc
- IQVIA Holdings Inc
- ICON Plc
- Cognizant Technology Solutions Corp
- Accenture Plc
- Syneos Health Inc
- Genpact Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For